Literature DB >> 19267394

Cytokines as genetic modifiers in K5-/- mice and in human epidermolysis bullosa simplex.

Wera Roth1, Ursula Reuter, Claudia Wohlenberg, Leena Bruckner-Tuderman, Thomas M Magin.   

Abstract

Epidermolysis bullosa simplex (EBS) is a skin disorder caused by fully-penetrant mutations in the keratin genes KRT5 and KRT14, leading to extensive cytolysis and cell fragility of basal keratinocytes. EBS is subject to environmental conditions and displays high intra- and interfamilial variability, suggesting modifying loci. Here, we demonstrate that upregulation of certain cytokines accompanies mutations in keratin 5 (K5) but not in keratin 14 (K14). We find for the first time that cytokines macrophage chemotactic protein (MCP)-1/[chemokine (C-C motif) ligand 2] (CCL2), macrophage inflammatory protein (MIP)-3beta/CCL19 and MIP-3alpha/CCL20, all regulated by nuclear factor kappa B (NFkappaB) and involved in the recruitment, maturation, and migration of Langerhans cells (LCs) in the epidermis, are upregulated in the skin of K5(-/-), but not of K14(-/-) mice. In neonatal K5(-/-) epidermis, the number of LCs was increased two-fold. At the same time, tumor necrosis factor alpha (TNFalpha) remained unaltered, demonstrating the specificity of that process. Most remarkably, enhanced LC recruitment within the epidermis was found in five EBS patients carrying mutations in the KRT5 gene but not in EBS patients with KRT14 gene mutations. In agreement with the NFkappaB-dependent regulation of these cytokines, we found a decrease in p120-catenin in the basal epidermis of K5(-/-) mice. These data provide the first explanation for distinct, keratin-type-specific genotype-phenotype correlations in EBS and represent a rationale to investigate gene loci affecting skin pathology in EBS. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267394     DOI: 10.1002/humu.20981

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

Authors:  Johannes S Kern; Stefan Loeckermann; Anja Fritsch; Ingrid Hausser; Wera Roth; Thomas M Magin; Claudia Mack; Marcel L Müller; Oliver Paul; Patrick Ruther; Leena Bruckner-Tuderman
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

2.  Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration.

Authors:  Vitali Alexeev; Julio Cesar Salas-Alanis; Francis Palisson; Lila Mukhtarzada; Giulio Fortuna; Jouni Uitto; Andrew South; Olga Igoucheva
Journal:  J Invest Dermatol       Date:  2017-07-20       Impact factor: 8.551

Review 3.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

4.  Keratin intermediate filament proteins - novel regulators of inflammation and immunity in skin.

Authors:  Ryan P Hobbs; Juliane C Lessard; Pierre A Coulombe
Journal:  J Cell Sci       Date:  2012-11-15       Impact factor: 5.285

5.  Directed expression of a chimeric type II keratin partially rescues keratin 5-null mice.

Authors:  David M Alvarado; Pierre A Coulombe
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

Review 6.  Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis.

Authors:  Cory L Simpson; Dipal M Patel; Kathleen J Green
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-23       Impact factor: 94.444

Review 7.  The expanding significance of keratin intermediate filaments in normal and diseased epithelia.

Authors:  Xiaoou Pan; Ryan P Hobbs; Pierre A Coulombe
Journal:  Curr Opin Cell Biol       Date:  2012-12-25       Impact factor: 8.382

Review 8.  Keratin gene mutations in disorders of human skin and its appendages.

Authors:  Jean Christopher Chamcheu; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Mirjana Liovic; Hasan Mukhtar
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

Review 9.  Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors:  Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

10.  Keratins regulate protein biosynthesis through localization of GLUT1 and -3 upstream of AMP kinase and Raptor.

Authors:  Preethi Vijayaraj; Cornelia Kröger; Ursula Reuter; Reinhard Windoffer; Rudolf E Leube; Thomas M Magin
Journal:  J Cell Biol       Date:  2009-10-19       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.